These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35570489)

  • 1. Ethnic-Specific Type 2 Diabetes Risk Factor PAX4 R192H Is Associated with Attention-Specific Cognitive Impairment in Chinese with Type 2 Diabetes.
    Ang SF; Low S; Ng TP; Tan CSH; Ang K; Lim Z; Tang WE; Subramaniam T; Sum CF; Lim SC
    J Alzheimers Dis; 2022; 88(1):241-249. PubMed ID: 35570489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX4 R192H is associated with younger onset of Type 2 diabetes in East Asians in Singapore.
    Ang SF; Tan CSH; Wang L; Dorajoo R; Fong JCW; Kon WYC; Lian JX; Ang K; Rahim JB; Jeevith B; Lee SBM; Tang WE; Subramanium T; Sum CF; Liu JJ; Lim SC
    J Diabetes Complications; 2019 Jan; 33(1):53-58. PubMed ID: 30528630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes.
    Kooptiwut S; Plengvidhya N; Chukijrungroat T; Sujjitjoon J; Semprasert N; Furuta H; Yenchitsomanus PT
    J Diabetes Complications; 2012; 26(4):343-7. PubMed ID: 22521316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense Variants in PAX4 Are Associated with Early-Onset Diabetes in Chinese.
    Gao A; Gu B; Zhang J; Fang C; Su J; Li H; Han R; Ye L; Wang W; Ning G; Wang J; Gu W
    Diabetes Ther; 2021 Jan; 12(1):289-300. PubMed ID: 33216280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects.
    Sujjitjoon J; Kooptiwut S; Chongjaroen N; Semprasert N; Hanchang W; Chanprasert K; Tangjittipokin W; Yenchitsomanus PT; Plengvidhya N
    J Hum Genet; 2016 Nov; 61(11):943-949. PubMed ID: 27334367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX4 mutations in Thais with maturity onset diabetes of the young.
    Plengvidhya N; Kooptiwut S; Songtawee N; Doi A; Furuta H; Nishi M; Nanjo K; Tantibhedhyangkul W; Boonyasrisawat W; Yenchitsomanus PT; Doria A; Banchuin N
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2821-6. PubMed ID: 17426099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals.
    Cheung CY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CH; Kwok KH; Chow WS; Woo YC; Yuen MM; Hai JS; Jin YL; Cheung BM; Tan KC; Cherny SS; Zhu F; Zhu T; Thomas GN; Cheng KK; Jiang CQ; Lam TH; Tse HF; Sham PC; Lam KS
    Diabetologia; 2017 Jan; 60(1):107-115. PubMed ID: 27744525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
    Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ
    Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4.
    Ma RC; Hu C; Tam CH; Zhang R; Kwan P; Leung TF; Thomas GN; Go MJ; Hara K; Sim X; Ho JS; Wang C; Li H; Lu L; Wang Y; Li JW; Wang Y; Lam VK; Wang J; Yu W; Kim YJ; Ng DP; Fujita H; Panoutsopoulou K; Day-Williams AG; Lee HM; Ng AC; Fang YJ; Kong AP; Jiang F; Ma X; Hou X; Tang S; Lu J; Yamauchi T; Tsui SK; Woo J; Leung PC; Zhang X; Tang NL; Sy HY; Liu J; Wong TY; Lee JY; Maeda S; Xu G; Cherny SS; Chan TF; Ng MC; Xiang K; Morris AP; ; Keildson S; ; Hu R; Ji L; Lin X; Cho YS; Kadowaki T; Tai ES; Zeggini E; McCarthy MI; Hon KL; Baum L; Tomlinson B; So WY; Bao Y; Chan JC; Jia W
    Diabetologia; 2013 Jun; 56(6):1291-305. PubMed ID: 23532257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsynonymous Variants in
    Kwak SH; Chae J; Lee S; Choi S; Koo BK; Yoon JW; Park JH; Cho B; Moon MK; Lim S; Cho YM; Moon S; Kim YJ; Han S; Hwang MY; Cho YS; Lee MS; Jang HC; Kang HM; Park T; Cho NH; Kim K; Kim JI; Park KS
    Diabetes; 2018 Sep; 67(9):1892-1902. PubMed ID: 29941447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of early-onset Type 2 diabetes with cognitive impairment is partially mediated by increased pulse pressure.
    Ang SF; Low SKM; Ng TP; Ang K; Yap PLK; Cheong CY; Lim Z; Tang WE; Moh AMC; Subramaniam T; Sum CF; Lim SC
    J Diabetes Complications; 2022 Jul; 36(7):108209. PubMed ID: 35660335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of correlation between the mild cognitive impairment (MCI) and level of adiponectin in elderly patients with type 2 diabetes mellitus (T2DM).
    Liu ZQ; Zhang MX; Wang J; Ding N
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5471-5477. PubMed ID: 29243792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients.
    Chen M; Hu C; Zhang R; Jiang F; Wang J; Peng D; Tang S; Sun X; Yan J; Luo Y; Bao Y; Jia W
    Pharmacogenomics J; 2014 Oct; 14(5):488-92. PubMed ID: 24752311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young.
    Jo W; Endo M; Ishizu K; Nakamura A; Tajima T
    Tohoku J Exp Med; 2011 Feb; 223(2):113-8. PubMed ID: 21263211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development.
    Lau HH; Krentz NAJ; Abaitua F; Perez-Alcantara M; Chan JW; Ajeian J; Ghosh S; Lee Y; Yang J; Thaman S; Champon B; Sun H; Jha A; Hoon S; Tan NS; Gardner DS; Kao SL; Tai ES; Gloyn AL; Teo AKK
    Nat Commun; 2023 Sep; 14(1):6119. PubMed ID: 37777536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of the PAX4 gene with type 1 diabetes in Han Chinese.
    Zhang Y; Xiao X; Liu Y; Zhu X; Wenhui L; Li N; Yuan T; Wang H
    Diabetes Res Clin Pract; 2008 Sep; 81(3):365-9. PubMed ID: 18617287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Plasma Level of Nampt Presaging Memory Dysfunction in Chinese Type 2 Diabetes Patients with Mild Cognitive Impairment.
    Huang X; Wang C; Tian S; Huang R; Guo D; Zhang H; Shi J; Wang S
    J Alzheimers Dis; 2019; 70(1):303-314. PubMed ID: 31177228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of mild cognitive impairment with type 2 diabetes mellitus among elderly people in China: A cross-sectional study.
    Gao Y; Xiao Y; Miao R; Zhao J; Cui M; Huang G; Fei M
    Arch Gerontol Geriatr; 2016; 62():138-42. PubMed ID: 26381432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Arg121Trp variant in PAX4 gene is associated with beta-cell dysfunction in Japanese subjects with type 2 diabetes mellitus.
    Tokuyama Y; Matsui K; Ishizuka T; Egashira T; Kanatsuka A
    Metabolism; 2006 Feb; 55(2):213-6. PubMed ID: 16423628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.